1.Research Methodology
1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.4.1.Assumptions
1.4.2.Forecast parameters
1.5.Data sources
1.5.1.Primary
1.5.2.Secondary
2.Executive Summary
2.1.360° summary
2.2.By Procedure trends
2.3.By End-User trends
3.Market overview
3.1.Market segmentation & definitions
3.2.Key takeaways
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.3.1.Bargaining power of consumers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of new entrants
3.3.4.Threat of substitutes
3.3.5.Competitive rivalry in the market
3.4.Market dynamics
3.4.1.Drivers
3.4.2.Restraints
3.4.3.Opportunities
3.5.Technology landscape
3.6.Regulatory landscape
3.7.Patent landscape
3.8.Market value chain analysis
3.8.1.Stress point analysis
3.8.2.Raw material analysis
3.8.3.Manufacturing process
3.8.4.Sales Channel analysis
3.8.5.Operating vendors
3.8.5.1.Raw material suppliers
3.8.5.2.Procedure manufacturers
3.8.5.3.Procedure distributors
3.9.Strategic overview
4.Percutaneous Aortic Valve Implantation Market, by Procedure
4.1.Overview
4.1.1.Market size and forecast, by Procedure
4.2.Transfemoral
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region, 2020-2028
4.2.3.Market share analysis, by country 2020 & 2028
4.3.Subclavian
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region, 2020-2028
4.3.3.Market share analysis, by country 2020 & 2028
4.4.Direct aortic
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region, 2020-2028
4.4.3.Market share analysis, by country 2020 & 2028
5.Percutaneous Aortic Valve Implantation Market, by End-User
5.1.Overview
5.1.1.Market size and forecast, by Sales Channel
5.2.Hospitals and Cardiac Centers
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region, 2020-2028
5.2.3.Market share analysis, by country 2020 & 2028
5.3.Ambulatory Surgical Center
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region, 2020-2028
5.3.3.Market share analysis, by country 2020 & 2028
6.Percutaneous Aortic Valve Implantation Market, by Region
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by Procedure , 2020-2028
6.2.3.Market size and forecast, by End-User , 2020-2028
6.2.4.Market size and forecast, by country, 2020-2028
6.2.5.U.S.
6.2.5.1.Market size and forecast, by Procedure , 2020-2028
6.2.6.Market size and forecast, by End-User , 2020-2028
6.2.7.Canada
6.2.7.1.Market size and forecast, by Procedure , 2020-2028
6.2.8.Market size and forecast, by End-User , 2020-2028
6.2.9.Mexico
6.2.10.Market size and forecast, by End-User , 2020-2028
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by Procedure , 2020-2028
6.3.3.Market size and forecast, by End-User , 2020-2028
6.3.4.Market size and forecast, by country, 2020-2028
6.3.5.Germany
6.3.5.1.Market size and forecast, by Procedure , 2020-2028
6.3.6.Market size and forecast, by End-User , 2020-2028
6.3.7.UK
6.3.7.1.Market size and forecast, by Procedure, 2020-2028
6.3.7.2.Market size and forecast, by End-User, 2020-2028
6.3.8.France
6.3.8.1.Market size and forecast, by Procedure, 2020-2028
6.3.8.2.Market size and forecast, by End-User, 2020-2028
6.3.9.Spain
6.3.9.1.Market size and forecast, by Procedure 2020-2028
6.3.9.2.Market size and forecast, by End-User, 2020-2028
6.3.10.Italy
6.3.10.1.Market size and forecast, by Procedure , 2020-2028
6.3.10.2.Market size and forecast, by End-User, 2020-2028
6.3.11.Rest of Europe
6.3.11.1.Market size and forecast, by Procedure , 2020-2028
6.3.11.2.Market size and forecast, by End-User , 2020-2028
6.4.Asia Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by Procedure , 2020-2028
6.4.3.Market size and forecast, by End-User , 2020-2028
6.4.4.Market size and forecast, by country, 2020-2028
6.4.5.China
6.4.5.1.Market size and forecast, by Procedure , 2020-2028
6.4.5.2.Market size and forecast, by End-User , 2020-2028
6.4.6.Japan
6.4.6.1.Market size and forecast, by Procedure , 2020-2028
6.4.6.2.Market size and forecast, by End-User , 2020-2028
6.4.7.India
6.4.7.1.Market size and forecast, by Procedure , 2020-2028
6.4.7.2.Market size and forecast, by End-User , 2020-2028
6.4.8.South Korea
6.4.8.1.Market size and forecast, by Procedure , 2020-2028
6.4.8.2.Market size and forecast, by End-User , 2020-2028
6.4.9.Australia
6.4.9.1.Market size and forecast, by Procedure , 2020 2028
6.4.9.2.Market size and forecast, by End-User , 2020-2028
6.4.9.3.Comparative market share analysis, 2020 & 2028
6.4.10.Rest of Asia Pacific
6.4.10.1.Market size and forecast, by Procedure , 2020-2028
6.4.10.2.Market size and forecast, by End-User , 2020-2028
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by Procedure , 2020-2028
6.5.2.1.Market size and forecast, by End-User , 2020-2028
6.5.3.Market size and forecast, by country, 2020-2028
6.5.4.Latin America
6.5.4.1.Market size and forecast, by Procedure , 2020-2028
6.5.4.2.Market size and forecast, by End-User , 2020-2028
6.5.5.Middle East
6.5.5.1.Market size and forecast, by Procedure , 2020-2028
6.5.5.2.Market size and forecast, by End-User , 2020-2028
6.5.6.Africa
6.5.6.1.Market size and forecast, by Procedure , 2020-2028
6.5.6.2.Market size and forecast, by End-User , 2020-2028
7.Company profiles
7.1. Boston Scientific Corporation
7.1.1.Company overview
7.1.2.Operating business segments
7.1.3.Procedure portfolio
7.1.4.Financial Performance
7.1.5.Recent strategic moves & developments
7.2. Abbott Laboratories
7.2.1.Company overview
7.2.2.Operating business segments
7.2.3.Procedure portfolio
7.2.4.Financial Performance
7.2.5.Recent strategic moves & developments
7.3.Becton Dickinson and Company
7.3.1.Company overview
7.3.2.Operating business segments
7.3.3.Procedure portfolio
7.3.4.Financial Performance
7.3.5.Recent strategic moves & developments
7.4.Bracco
7.4.1.Company overview
7.4.2.Operating business segments
7.4.3.Procedure portfolio
7.4.4.Financial Performance
7.4.5.Recent strategic moves & developments
7.5.Edwards Lifesciences Corporation
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Procedure portfolio
7.5.4.Financial Performance
7.5.5.Recent strategic moves & developments
7.6.JenaValve Techologies Inc.,
7.6.1.Company overview
7.6.2.Operating business segments
7.6.3.Procedure portfolio
7.6.4.Financial Performance
7.6.5.Recent strategic moves & developments
7.7.Venus Medtech
7.7.1.Company overview
7.7.2.Operating business segments
7.7.3.Procedure portfolio
7.7.4.Financial Performance
7.7.5.Recent strategic moves & developments
7.8. Medtronic Plc.,
7.8.1.Company overview
7.8.2.Operating business segments
7.8.3.Procedure portfolio
7.8.4.Financial Performance
7.8.5.Recent strategic moves & developments
7.9.Meril Lifesciences
7.9.1.Company overview
7.9.2.Operating business segments
7.9.3.Procedure portfolio
7.9.4.Financial Performance
7.9.5.Recent strategic moves & developments
7.10.JC Medical Inc.
7.10.1.Company overview
7.10.2.Operating business segments
7.10.3.Procedure portfolio
7.10.4.Financial Performance
7.10.5.Recent strategic moves & developments
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/